APA (7th ed.) Citation

Ferrari, M., Parekh, F., Maciocia, P., Horna, P., Thomas, S., Sewell, A. K., & Pule, M. Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies. Nature Portfolio.

Chicago Style (17th ed.) Citation

Ferrari, Mathieu, Farhaan Parekh, Paul Maciocia, Pedro Horna, Simon Thomas, Andrew K. Sewell, and Martin Pule. Reply to: Oligoclonality of TRBC1 and TRBC2 in T Cell Lymphomas as Mechanism of Primary Resistance to TRBC-directed CAR T Cell Therapies. Nature Portfolio.

MLA (9th ed.) Citation

Ferrari, Mathieu, et al. Reply to: Oligoclonality of TRBC1 and TRBC2 in T Cell Lymphomas as Mechanism of Primary Resistance to TRBC-directed CAR T Cell Therapies. Nature Portfolio.